Master's Programme in Biopharmaceuticals
120 credits
Outline, FBL2M
- Code
- FBL2M
- Finalised by
- The Educational Board of Pharmacy, 9 June 2022
- Registration number
- MEDFARM 2020/1079
Semester 1
- Biopharmaceuticals: Orientation Course for Master's Students, 7.5 credits (3FB059) Main field(s) of study and in-depth level: Drug Discovery and Development A1N
- Biologicals I, 7.5 credits (3FB028) Main field(s) of study and in-depth level: Drug Discovery and Development A1N, Pharmaceutical Sciences A1N
- Life Cycle Analysis of Biologicals, 7.5 credits (3FS010) Main field(s) of study and in-depth level: Drug Discovery and Development A1N, Pharmaceutical Sciences A1N
- Pharmacokinetics and Pharmacodynamics of Biological Drugs, 7.5 credits (3FB037) Main field(s) of study and in-depth level: Drug Discovery and Development A1N, Pharmaceutical Sciences A1N
Semester 2
- Pharmaceutical Protein Drug Development, 7.5 credits (3FB031) Main field(s) of study and in-depth level: Drug Discovery and Development A1F, Pharmaceutical Sciences A1F
- Development of Biologicals, 7.5 credits (1KB429) Main field(s) of study and in-depth level: Chemistry A1F, Pharmaceutical Sciences A1F
- Proteomics for Drug Discovery, 7.5 credits (3FF031) Main field(s) of study and in-depth level: Drug Discovery and Development A1N, Pharmaceutical Sciences A1N
- Computational Pharmaceutics, 7.5 credits (3FG005) Main field(s) of study and in-depth level: Drug Discovery and Development A1N, Pharmaceutical Sciences A1N
Semester 3
During the second year, the student chooses courses.
Elective courses 15 credits and part of a Master's project 45 credits or elective courses 30 credits.
Semester 4
Master's project 30 credits or remaining part of Master's project 45 credits.